Clinical Trial Update: Epidemiology and Biomarker Study in Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on an epidemiology and biomarker study in Alzheimer's disease sponsored by Eli Lilly; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease | Phase 3 | Status: RECRUITING